Re: Singer et al.: Fluocinolone acetonide implant as a baseline therapy for diabetic macular edema: results from the randomized phase 4 NEW DAY study (Ophthalmology. 2026;133:837-851).
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.